Xema Co., Ltd. of Moscow at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Xema Co., Ltd.

48, The 9th Parkovaya St., 105264 Moscow
Russian Federation
Telephone +7 495 7373936
Fax +7 495 7370040

Hall map

MEDICA 2019 hall map (Hall 3): stand J51

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.01  Analyser systems / equipment

Analyser systems / equipment

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer

Diagnostic tests for cancer

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.01  Bacteriology testing

Bacteriology testing

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.02  Microbiological diagnosis, virology, equipment and systems for

Microbiological diagnosis, virology, equipment and systems for

About us

Company details

The Xema Corporate Group started in February 1993 as the private company Xema Co. Ltd. in Moscow, Russia. Over the course of twenty years, Xema has developed from a small-scale contract manufacturer of human antigen proteins to one of the world’s leading biological companies in providing tumor marker antigens and corresponding monoclonal antibodies. With our broad hybridoma collection, Xema now has the ability for the large-scale production of purified monoclonal antibodies for in vitro diagnostic use.

Currently, Xema conducts active research onthe following topics:
- Biochemistry and immunology of human tumor biomarkers (e.g., CEA, CA125/MUC16, MUC1,CA19-9, CA72-4, cytokeratines, and HE4)
- Development and validation of immunoassays of hormones, inflammation, and tumor markers for animal and agricultural diagnostics
- Immunochemistry of food antigens and food contaminants

We expanded our business in 1997 to the manufacturing of a broad panel of ELISA kits and lateral flow rapid devices for the detection of hormones; tumor markers; prenatal, neonatal, thyroid autoimmunity, cardiac and inflammation markers; and infection serology. Xema’s IVD kit development, production and sales in Russia have been certified with ISO 13485 since 2009. In Russia, Xema’s premises are located in both the city and suburban industrial area of Moscow. We also opened a plant of R&D and small scale production in St. Petersburg in 2004

After our successful operations in Russia, Xema initiated global business by setting up our worldwide sister companies. These international companies not only distribute Xema’s products, but also performXema’s R&D and production activities to meet the demands of local markets.

We are proud to announce the following sister companies:
* The joint venture Xemma-Test in Minsk, Belarus (est. 2003)
* Xema Co. Ltd. In Kiev, Ukraine (est. 2008)
* Xema OY in Lappeenranta, Finland (est. 2011).
* Hema Biotech Beijing Co Ltd in China (est. 2011)
* Xema Sdn Bhd in Malaysia (est. 2013)
* Xemabio LLC in Gainesville, Florida, USA (est. 2014)

Xema continues to develop, improve, and expand our research, products, and services to meet the high standards and expectations of our clients. We look forward to having business with you.

More Less